Loading clinical trials...
Loading clinical trials...
This study is a randomized, double-blind, placebo-controlled trial designed to examine the effects of pre-sleep creatine monohydrate supplementation on anaerobic performance and muscle damage markers in recreationally active females. Participants will be randomly assigned to receive either 5 grams of creatine monohydrate or a placebo 30 minutes before sleep for seven consecutive days. Anaerobic performance will be assessed using the Wingate Anaerobic Test, evaluating peak and average power output and fatigue index. Blood samples will be collected before and after the supplementation period to analyze markers of muscle damage, including creatine kinase and lactate dehydrogenase. This study aims to provide insight into the efficacy of short-term, time-specific creatine supplementation for enhancing performance and recovery.
Age
18 - 25 years
Sex
FEMALE
Healthy Volunteers
Yes
Islamic Azad University, Shabestar Branch
Shabestar, East Azerbaijan Province, Iran
Start Date
April 1, 2025
Primary Completion Date
May 10, 2025
Completion Date
July 10, 2025
Last Updated
April 22, 2025
24
ESTIMATED participants
Creatine Monohydrate
DIETARY_SUPPLEMENT
Placebo (Maltodextrin)
DIETARY_SUPPLEMENT
Lead Sponsor
Ankara Yildirim Beyazıt University
NCT07472244
NCT07252778
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT04549610